Cancer portrays a colossal range of infections that all begin from uncontrolled cell development. Comprehensively separated into bening tumors (incapable to metastasize) or malignant tumors (ready to attack typical tissues), malignant growths are additionally characterized and arranged by their cell type, tissue, or organ of cause. Malignancy remains the number two reason for death in the U.S., second just to coronary illness, and the Intramural Research Program (IRP) is focused on propelling exploration, building aptitude, and utilizing assets to address this worldwide test. Our researchers are continually getting familiar with the reasons for malignant growth, and growing new and better approaches to forestall, distinguish, and treat it.
Awards 2021: Journal of Cancer Clinical Trials
Awards 2021: Journal of Cancer Clinical Trials
Case Report: Journal of Cancer Clinical Trials
Case Report: Journal of Cancer Clinical Trials
Short Communication: Journal of Cancer Clinical Trials
Short Communication: Journal of Cancer Clinical Trials
Scientific Tracks Abstracts: Journal of Clinical Case Reports
Scientific Tracks Abstracts: Journal of Clinical Case Reports
Posters & Accepted Abstracts: Journal of AIDS & Clinical Research
Posters & Accepted Abstracts: Journal of AIDS & Clinical Research
Posters & Accepted Abstracts: Journal of Cosmetology & Trichology
Posters & Accepted Abstracts: Journal of Cosmetology & Trichology
Journal of Cancer Clinical Trials received 95 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 